Diet Pill Meridia
Over one hundred billion dollars were spent last year on over-the-counter
diet aids in 2001 and had a 95% failure rate. Americans continue
to buy diet pills to combat the growing problem of obesity in this
country. When Fen Phen was approved it had immediate success and
substantial results. Americans fled to their doctors for the breakthrough
in diet pills, but the pill claimed too good to be true. In 1997,
Fen Phen was withdrawn from the market after 6-7 million Americans
took the diet pill and many suffered heart valve disease and Primary
Pulmonary Hypertension that resulted in numerous class actions and
individual lawsuits.
In 1996, an FDA advisory committee voted against the approval of
the diet pill Meridia because it raised
blood pressure and more information was needed. The FDA still
approved Meridia one year later despite the ban of the two previous
diet pills linked to serious risks and Meridia
side effects. The FDA warned upon approval, stating that the
diet pill Meridia can cause increases in blood pressure and pulse
rate that may endanger certain patients. Dr. James Bilstad of the
FDA stated "we still have some concern" but that the diet
pill Meridia did not appear to pose the risk of heart valve damage
that Redux, fenfluramine, and Fen Phen did.
The 29 U.S. Meridia deaths have been mainly linked to heart problems.
Public Citizen petitioned the FDA for the immediate ban of Meridia
in March 2002 because they found "there is no evidence that
the drug has prolonged the life of a single patient, or reduced
the risks of strokes or heart attack tied to obesity. Instead, it
has left patients with only higher risks of injury or death from
using it- and high drug bills." Dr. Sidney Wolfe of Public
Citizen predicts the diet pill Meridia will be taken off the market,
but Abbott Laboratories continues to stand by their diet pill.
Most recently, Public Citizen urged U.S officials to bring criminal
charges against Abbott Laboratories because they said the pharmaceutical
giants illegally withheld information from regulators regarding
eight Meridia deaths and other side effects in Meridia patients.
From the time of approval, Abbott Laboratories has tried hard to
distinguish their diet pill Meridia from the then recently withdrawn
diet pill Fen Phen that cost the lives and health of countless people.
Now Abbott is facing problems of their own, and if they have in
fact failed to report Meridia deaths that are required by law to
report, they can stand in violation and for knowingly risking the
lives of all Meridia patients by withholding information.
For the 58 million, and growing, number of overweight Americans,
the search for a diet pill miracle will continue regardless of Meridia's
outcome. Researchers are continuing to study how to trick the brain
into wanting less food in order to prevent instances of binging.
The future of diet pills is the development of drugs like Axokine
that are now being developed, but they will not be available for
a few years. The health problems that Fen Phen and now Meridia are
having will certainly be on the minds of the FDA when approving
the newest breakthrough in diet pills.
|